期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

P16^(INK4a)和P14^(ARF)蛋白在喉鳞癌中的表达及临床意义

Expression and significance of P16^(INK4a) and P14^(ARF) proteins in laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨P16INK4a和P14ARF蛋白在喉鳞状细胞癌组织中的表达及其临床意义。方法采用免疫组织化学EnVision法检测71例喉鳞状细胞癌组织中P16INK4a和P14ARF蛋白的表达。结果 71例喉鳞状细胞癌标本中,35例(49.3%)P16INK4a蛋白阴性,29例(40.8%)P14ARF蛋白阴性,15例(21.1%)P16INK4a和P14ARF蛋白表达均阴性。P16INK4a和P14ARF蛋白阴性间无相关性(P>0.05)。P16INK4a和P14ARF蛋白阴性率均与患者性别、年龄及临床分期无相关性(P>0.05)。P14ARF蛋白在I～II期病例中强阳性占阳性比例为41.7%,在III～IV期中强阳性比例为11.1%。结论 P16INK4a和P14ARF在喉鳞状细胞癌发生过程中起重要作用,两种蛋白的失活是各自独立的事件。P14ARF蛋白的缺失发生在喉鳞状细胞癌早期。 Objective To study the expression and clinical significance of P16INK4a and P14ARF proteins in laryn- geal squamous cell carcinoma. Methods The expression of P16INK4a and P14ARF proteins was detected in 71 carcinoma samples by immunohistochemistry （ EnVision method）. Results The negative expression of P16INK4a and P14ARF was de- tected in 35 samples（49.3 % ）and 29 sanlples（40.8 % ） respectively. While 15 cases（21.1% ）showed simultaneous loss in both proteins. Rank correlation analysis revealed that there was no correlation between negative expression of P16INK4a and P14ARF proteins in carcinoma（ P 〉 0.05 ）. The negative expression rate of P16INK4a and P14ARF was unrelated to the clinical data including gender, age and clinical stage. The overpositive proportion of all P14ARF positive cases in stage I to II was 41.7% and 11.1% in stage III to IV. Conclusions The aberrance of P16INK4a and P14ARF gene might be as- sociated with the oncogenesis of carcinoma. There was no correlation between negative expression of P16INK4a and P14ARF proteins in carcinoma. Moreover, the loss of P14ARF protein occurred in the early stage of carcinoma. （ Chin J Ophthalmol and Otorhinolaryngo1,2010,10：218-220）
作者 朱莉 王纾宜 李诗敏
机构地区 复旦大学附属眼耳鼻喉科医院病理科
出处 《中国眼耳鼻喉科杂志》 2010年第4期218-220,274,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
关键词 喉肿瘤 鳞状细胞癌 P16INK4A P14ARF’ 免疫组织化学 蛋白表达 Laryngeal neoplasm Squamous cell carcinoma P16INK4a P14ARF Immunohistochemistry Prptein expression
分类号 R739.65 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1GIBSON S L,DAI C Y,LEE H W,et al.Inhihition of colon tumor progression and angiogenesi8 by the Ink4a/Arf locus[J].Cancer Res,2003,63 (4):742-746.
  • 2MAGDINIER F,WOLFFE A P.Selective association of the methylCpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia[J].Proc Natl Acad Sci U S A,2001,98 (9):4990-4995.
  • 3KUO M L,DUNCAVAGE E J,MATHEW R,et al.Arf induces p53-dependent and-independent antiproliferative genes[J].Cancer Res,2003,63 (5):1046-1053.
  • 4ZHANG Y,XIONG Y,YARBROUGH W G,et al.ARF promotes MDM2 degradation and stahilizes p53:ARF-INK4a locus deletion impairs hoth the Rb and p53 tumor suppression pathways[J].Cell,1998,92 (6):725-734.
  • 5SILVA J,SILVA J M,DOMINGUEZ G,et al.Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms[J].J Pathol,2003,199 (3):289-297.
  • 6BATES S,PHILLIPS A C,CLARK P A,et al.p14^ARF links the tumor suppressors RB and p53[J].Nature,1998,395 (6698):124-125.
  • 7李军果,叶明福,胡义德.小细胞肺癌p14^(ARF)、p16^(INK4a)蛋白表达及其临床意义[J].第三军医大学学报,2004,26(12):1098-1101. 被引量：1
  • 8THOMPSON P M,MARIS J M,HOCARTY M D,et al.Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma[J].Cancer Res,2001,61 (2):679-686.
  • 9BAZAN V,ZANNA I,MICLIAVACCA M,et al.Prognostic significance of P16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma[J].J Cell Physiol,2002,192(3):286-293.
  • 10黄红彦,崔永华,唐大椿,陶雁玲,刘秋润.p16基因突变与喉癌生物学行为的相关性[J].临床耳鼻咽喉科杂志,2001,15(6):253-254. 被引量：3

二级参考文献14

  • 1Fueyo J，Oncogene，1996年，12卷，103页
  • 2Herman J G，Cancer Res，1995年，55卷，4525页
  • 3Nobori T，Nature，1994年，368卷，753页
  • 4Quelle DE, Zindy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell,1995, 83(6):993-1 000.
  • 5Galloway DA & McDougall JK. The disruption of cell cycle checkpoint by papillomavrus oncoproteins contributes to anogenital neoplasia. Semin Cancer Biol, 1996, 7(6):309-15.
  • 6Guimaraes MC, Goncalves MA, Soares CP, et al. Immunohistochemical expression of p16^INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. Histochem Cytochem, 2005, 53(4):509-16.
  • 7Volgareva G, Zavalishina L, Andreeva Y, et al. Protein p 16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer, 2004, 4(1):58.
  • 8Wang JL, Zheng BY, Li XD, et al. Predictive significance of the alterations of p16^INK4A, p14^ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res, 2004, 10(7):2 407-14.
  • 9Rocco JW & Sidransky D. P16 (MTS-1 /CDKN2/INK4a) in cancer progression. Experimental Cell Res, 2001,264(1):42-55.
  • 10Kumar R, Smeds J, Lundh B, et al. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus):homczygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas. Melanoma Res,1999, 9(2):138-47.

共引文献7

中国眼耳鼻喉科杂志
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部